By Irene Gladstein | January 31, 2023
Over the last decade, the popularity of and market for dermal fillers has grown significantly, with more than three million people currently receiving injectable fillers each year, according to the Cleveland Clinic.1 Dermal fillers can help replace lost ...
Results from Teenage Trial of Abrocitnib in Adoles
-Observed improvements in skin clearance, disease extent, and severity among patients 12 to 18- -Safety profile consistent with other pivotal studies of abrocitinib reported to date- NEW YORK-- Pfizer Inc. (NYSE: PFE) announced today positive top-line ...